Haji MUHAMMAD, Bushra ISMAIL, Afaq Ullah KHAN, Faheem SHAH, Rafaqat Ali KHAN, Asad Mohammad KHAN

Preconcentration of rifampicin prior to its efficient spectroscopic determination in the wastewater samples based on a nonionic surfactant

Every year, tuberculosis affects the lungs of millions of people and rifampicin is the commonly used medicine for its treatment due to its antibiotic nature. The frequent use of rifampicin may lead to its increased concentration in the water resources. This research work is focused on the cloud point extraction (CPE) procedure for the preconcentration of rifampicin prior to its determination in water. The UV/vis spectrophotometric method was adapted for the measurement of rifampicin content after the phase separation. Triton-X 100 was used as the nonionic surfactant which contains hydrophilic polyethylene chain feasible for the extraction of analyte. Various analytical parameters that can affect the extraction efficacy were optimized to achieve linearity of the proposed method in the concentration range of 3.54–81.41 $mgL^{–1},$. The Limit of detection and quantification were 1.261 and 4.212 $mgL^{–1},$ respectively. The Preconcentration factor was 40 with relative standard deviation (%RSD) of 2.504%. The standard addition methodology was adopted for the validation of this procedure and effectively applied for the determination of rifampicin in real wastewater samples.

PDF

___

1. Jongrungruangchok S, Songsak T. Validation of HPLC methods for determination of isoniazid, rifampicin, pyrazinamide, and ethambutolin a fixed-dose combination antituberculosis. Bulletin of Health, Science and Technology 2015; 13 (1): 17-28.
2. Storla DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 2008; 8 (1): 1-9. doi: 10.1186/1471-2458-8-15
3. Koul A, Arnoult E, Lounis N, Guillemont J, Andries K. The challenge of new drug discovery for tuberculosis. Nature 2011; 469 (7331): 483-490. doi: 10.1038/nature09657
4. Maggi N, Pasqualucci CR, Ballotta R, Sensi P. Rifampicin: a new orally active rifamycin. Chemotherapy 1966; 11 (5): 285-292. doi: 10.1159/000220462
5. Deepa P, Therese KL, Madhavan HN. Detection and characterization of mutations in rifampicin resistant Mycobacterium tuberculosis clinical isolates by DNA sequencing. Indian Journal of Tuberculosis 2005; 52 (3): 132-136.
6. Panchagnula R, Sood A, Sharda N, Kaur K, Kaul CL. Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method. Journal of Pharmaceutical and Biomedical analysis 1999; 18 (6): 1013-1020. doi: 10.1016/ S0731-7085(98)00112-5
7. Mitchison DA. Basic mechanisms of chemotherapy. Chest 1979; 76 (6): 771-780. doi: 10.1378/chest.76.6.771
8. Diggelmann H, Weissmann C. Rifampicin inhibits focus formation in chick fibroblasts infected with Rous sarcoma virus. Nature 1969; 224 (5226): 1277-1279. doi: 10.1038/2241277a0
9. Hobby GL. Summation of experimental studies on the action of rifampin. Chest 1972; 61 (6): 550-554. doi: 10.1378/chest.61.6_ Supplement.550
10. Tatarczak M, Flieger J, Szumieo H. High perfomance liquid chromatographic determination of rifampicin in complex pharmaceutical preparation and in serum of Mycobacterium tuberculosis-infected patients. Acta Poloniae Pharmaceutica-Drug Research 2005; 62 (4): 251-256.
11. Cayley FE, Majumdar SK. Ocular toxicity due to rifampicin. British Medical Journal. 1976; 241 (6003): 199-200. doi: 10.1136/ bmj.1.6003.199-a
12. Polesky A, Farber HW, Gottlieb DJ, Park H, Levinson S et al. Rifampin preventive therapy for tuberculosis in Boston’s homeless. American Journal of Respiratory and Critical Care Medicine 1996; 154 (5): 1473-1477. doi: 10.1164/ajrccm.154.5.8912767
13. Pratt TH. Rifampin-induced organic brain syndrome. The Journal of the American Medical Association 1979; 241 (22): 2421-2422. doi: 10.1001/jama.1979.03290480055027
14. Samanidou VF, Nikolaidou KI, Papadoyannis IN. Advances in chromatographic analysis of tetracyclines in foodstuffs of animal origin—a review. Separation & Purification Reviews 2007; 36 (1): 1-69. doi: 10.1080/15422110600822758
15. Kurniati Z, Riyanto S, Rohman A. Determination of rifampicin, isoniazid, pyrazinamide and ethambutol hydrochloride in 4FDC tablet by FTIR spectrophotometry in combination with multivariate calibration. Journal of Food and Pharmaceuticals Sciences 2016; 4 (2): 1923- 1930. doi.org/10.14499/jfps
16. Gong Z, Basir Y, Chu D, McCort-Tipton M. A rapid and robust liquid chromatography/tandem mass spectrometry method for simultaneous analysis of anti-tuberculosis drugs—ethambutol and pyrazinamide in human plasma. Journal of Chromatography B 2009; 877 (16-17): 1698-1704. doi: 10.1016/j.jchromb.2009.04.023
17. Olszowy P, Szultka M, Fuchs P, Kegler R, Mundkowski R et al. New coated SPME fibers for extraction and fast HPLC determination of selected drugs in human blood. Journal of Pharmaceutical and Biomedical Analysis 2010; 53 (4): 1022-1027. doi: 10.1016/j.jpba.2010.07.002
18. Al-Saidi HM, Emara AA. The recent developments in dispersive liquid–liquid microextraction for preconcentration and determination of inorganic analytes. Journal of Saudi Chemical Society 2014; 18 (6): 745-761. doi: 10.1016/j.jscs.2011.11.005
19. Manzoori JL, Karim-Nezhad G. Development of a cloud point extraction and preconcentration method for Cd and Ni prior to flame atomic absorption spectrometric determination. Analytica Chimica Acta 2004; 521 (2): 173-177. doi: 10.1016/j.aca.2004.06.049
20. An L, Deng J, Zhou L, Li H, Chen F et al. Simultaneous spectrophotometric determination of trace amount of malachite green and crystal violet in water after cloud point extraction using partial least squares regression. Journal of Hazardous Materials 2010; 175 (1-3): 883-888. doi: 10.1016/j.jhazmat.2009.10.092
21. Manzoori JL, Bavili-Tabrizi A. The application of cloud point preconcentration for the determination of Cu in real samples by flame atomic absorption spectrometry. Microchemical Journal 2002; 72 (1): 1-7. doi: 10.1016/S0026-265X(01)00113-8
22. Fröschl B, Stangl G, Niessner R. Combination of micellar extraction and GC-ECD for the determination of polychlorinated biphenyls (PCBs) in water. Fresenius’ Journal ofAnalytical Chemistry 1997; 357 (6): 743-746. doi: 10.1007/s002160050241
23. Soylak M, Dogan M. Column preconcentration of trace amounts of copper on activated carbon from natural water samples. Analytical Letters 1996; 29 (4): 635-643. doi: 10.1080/00032719608000426
24. Tavakoli L, Yamini Y, Ebrahimzadeh H, Nezhadali A, Shariati S et al. Development of cloud point extraction for simultaneous extraction and determination of gold and palladium using ICP-OES. Journal of Hazardous Materials 2008; 152 (2): 737-743. doi: 0.1016/j. jhazmat.2007.07.039
25. Soylak M, Elci L, Doğan M. Determinations of some trace metals in dialysis solutions by atomic absorption spectrometry after preconcentration. Analytical Letters 1993; 26 (9): 1997-2007. doi: 10.1080/00032719308017446
26. Calleja I, Blanco-Prı eto MJ, Ruz N, Renedo MJ, Dios-Viéitez MC. High-performance liquid–chromatographic determination of rifampicin in plasma and tissues. Journal of Chromatography A 2004; 1031 (1-2): 289-294. doi: 10.1016/j.chroma.2003.12.041
27. Liu Z, Yin P, Gong H, Li P, Wang X, He Y. Determination of rifampicin based on fluorescence quenching of GSH capped CdTe/ZnS QDs. Journal of Luminescence 2012 ; 132 (9): 2484-2488. doi: 10.1016/j.jlumin.2012.03.072
28. Panchagnula R, Sood A, Sharda N, Kaur K, Kaul CL. Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method. Journal of Pharmaceutical and Biomedical Analysis 1999; 18 (6): 1013-1020. doi:10.1016/ S0731-7085(98)00112-5
29. Liu J, Sun J, Zhang W, Gao K, He Z. HPLC determination of rifampicin and related compounds in pharmaceuticals using monolithic column. Journal of Pharmaceutical and Biomedical Analysis 2008; 46 (2): 405-409. doi: 10.1016/j.jpba.2007.10.025
30. Allanson AL, Cotton MM, Tettey JN, Boyter AC. Determination of rifampicin in human plasma and blood spots by high performance liquid chromatography with UV detection: a potential method for therapeutic drug monitoring. Journal of Pharmaceutical and Biomedical Analysis 2007; 44 (4): 963-969. doi: 10.1016/j.jpba.2007.04.007
31. Oliveira PR, Schibelbain AF, Neiva EG, Zarbin AJ, Marcolino-Junior LH et al. Nickel hexacyanoferrate supported at nickel nanoparticles for voltammetric determination of rifampicin. Sensors and Actuators B: Chemical 2018; 260: 816-823. doi: 10.1016/j.snb.2017.12.198